Syndecan-1-mediated cell spreading requires signaling by alphavbeta3 integrins in human breast carcinoma cells
- PMID: 12749851
- DOI: 10.1016/s0014-4827(03)00126-5
Syndecan-1-mediated cell spreading requires signaling by alphavbeta3 integrins in human breast carcinoma cells
Abstract
Syndecans are cell surface heparan sulfate proteoglycans with regulatory roles in cell adhesion, proliferation, and differentiation [Annu. Rev. Biochem. 68 (1999) 729]. While the syndecan heparan sulfate chains are essential for matrix binding, less is known about the signaling role of their core proteins. To mimic syndecan-specific adhesion, MDA-MB-231 mammary carcinoma cells were plated on antibodies against syndecan-4 or syndecan-1. While cells adherent via syndecan-4 spread, cells adherent via syndecan-1 do not. However, cells adherent via syndecan-1 can be induced to spread by Mn(2+), suggesting that activation of a beta(1) or beta(3) integrin partner is required. Surprisingly, pretreatment of cells with a function-activating beta(1) antibody does not induce spreading, whereas function-blocking beta(1) integrin antibodies do, suggesting involvement of a beta(1)-to-beta(3) integrin cross-talk. Indeed, blockade of beta(1) integrin activation induces alpha(v)beta(3) integrin activation detectable by soluble fibrinogen binding. Spreading in response to syndecan-1 is independent of integrin-ligand binding. Furthermore, competition with soluble murine syndecan-1 ectodomain, which does not disrupt cell adhesion, nonetheless blocks the spreading mechanism. These data suggest that the ectodomain of the syndecan-1 core protein directly participates in the formation of a signaling complex that signals in cooperation with alpha(v)beta(3) integrins; signaling via this complex is negatively regulated by beta(1) integrins.
Similar articles
-
The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells.J Cell Biol. 2004 Oct 11;167(1):171-81. doi: 10.1083/jcb.200404171. J Cell Biol. 2004. PMID: 15479743 Free PMC article.
-
Syndecan-1 signals independently of beta1 integrins during Raji cell spreading.Exp Cell Res. 2000 Sep 15;259(2):315-25. doi: 10.1006/excr.2000.4981. Exp Cell Res. 2000. PMID: 10964499
-
The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading.J Cell Biol. 2000 May 29;149(5):1143-56. doi: 10.1083/jcb.149.5.1143. J Cell Biol. 2000. PMID: 10831617 Free PMC article.
-
Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-αvβ3 integrin complex in tumorigenesis and angiogenesis.FEBS J. 2013 May;280(10):2207-15. doi: 10.1111/febs.12160. Epub 2013 Feb 24. FEBS J. 2013. PMID: 23375101 Free PMC article. Review.
-
Specific structural features of syndecans and heparan sulfate chains are needed for cell signaling.Braz J Med Biol Res. 2006 Feb;39(2):157-67. doi: 10.1590/s0100-879x2006000200001. Epub 2006 Feb 2. Braz J Med Biol Res. 2006. PMID: 16470302 Review.
Cited by
-
Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma.Tumour Biol. 2016 Sep;37(9):11573-11588. doi: 10.1007/s13277-016-5118-7. Epub 2016 Jun 18. Tumour Biol. 2016. PMID: 27317256 Review.
-
Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation.J Cell Sci. 2010 Nov 1;123(Pt 21):3796-807. doi: 10.1242/jcs.067645. J Cell Sci. 2010. PMID: 20971705 Free PMC article.
-
Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity.J Cell Biochem. 2014 May;115(5):967-76. doi: 10.1002/jcb.24746. J Cell Biochem. 2014. PMID: 24357546 Free PMC article.
-
Effects of syndecan-1 on the expression of syntenin and the migration of U251 glioma cells.Oncol Lett. 2017 Dec;14(6):7217-7224. doi: 10.3892/ol.2017.7170. Epub 2017 Oct 11. Oncol Lett. 2017. PMID: 29344156 Free PMC article.
-
Syndecans as Cell Surface Receptors in Cancer Biology. A Focus on their Interaction with PDZ Domain Proteins.Front Pharmacol. 2016 Feb 2;7:10. doi: 10.3389/fphar.2016.00010. eCollection 2016. Front Pharmacol. 2016. PMID: 26869927 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous